Lisofylline, a Novel Antiinflammatory Agent, Protects Pancreatic β-Cells from Proinflammatory Cytokine Damage by Promoting Mitochondrial Metabolism.

Proinflammatory cytokine-mediated pancreatic β-cell dysfunction is a key pathological event in type I diabetes mellitus. Lisofylline (LSF), an anti-inflammatory agent, has been shown to protect pancreatic islets from IL-1β-induced inhibitory effects on insulin release. However, the mechanism of LSF action is not known. Increasing evidence suggests that the mitochondria play an important role in regulating the β-cell insulin release capacity and the control of cellular viability. To examine the direct effects of LSF on β-cells, insulin-secreting INS-1 cells were exposed to a combination of recombinant IL-1β, TNFα, and IFNγ with or without LSF for 18 h. Basal and glucose-stimulated static insulin release were measured using RIA. INS-1 cell viability was determined using in situ terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling and LIVE/DEAD dual fluorescence labeling. To evaluate INS-1 mitochondrial function, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) metabolism, c...

[1]  M. Prentki,et al.  Dehydroepiandrosterone sulfate and beta-cell function: enhanced glucose-induced insulin secretion and altered gene expression in rodent pancreatic beta-cells. , 2000, Diabetes.

[2]  C. Du,et al.  Amelioration of CR-EAE with lisofylline: effects on mRNA levels of IL-12 and IFN-γ in the CNS , 2000, Journal of Neuroimmunology.

[3]  J. Martinou,et al.  Mitochondria as the central control point of apoptosis. , 2000, Trends in cell biology.

[4]  Dongbo Liu,et al.  Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). , 2000, Diabetes.

[5]  M. Fink,et al.  Lisofylline ameliorates intestinal and hepatic injury induced by hemorrhage and resuscitation in rats , 2000, Critical care medicine.

[6]  Y Li,et al.  [Mitochondria and apoptosis]. , 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[7]  G. Kroemer,et al.  The mitochondrion in cell death control: certainties and incognita. , 2000, Experimental cell research.

[8]  C. Wollheim,et al.  Beta-cell mitochondria in the regulation of insulin secretion: a new culprit in Type II diabetes , 2000, Diabetologia.

[9]  D. Hanahan,et al.  Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion. , 2000, American journal of physiology. Endocrinology and metabolism.

[10]  S. Klaus,et al.  Selective pharmacologic inhibition of murine and human IL-12-dependent Th1 differentiation and IL-12 signaling. , 1999, Journal of immunology.

[11]  P. Ronner,et al.  Luminometric assays of ATP, phosphocreatine, and creatine for estimation of free ADP and free AMP. , 1999, Analytical biochemistry.

[12]  G. Korbutt,et al.  Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. , 1999, Diabetes.

[13]  G. Fantuzzi,et al.  Effects of lisofylline on hyperoxia-induced lung injury. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[14]  M. Fink,et al.  Lisofylline ameliorates intestinal mucosal barrier dysfunction caused by ischemia and ischemia/reperfusion. , 1999, Shock.

[15]  G. A. Murphy,et al.  Selective downregulation of neutrophils by a phosphatidic acid generation inhibitor in a porcine sepsis model. , 1999, The Journal of surgical research.

[16]  S. Sriram,et al.  Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-1-mediated Th1 differentiation; an effect of the novel anti-inflammatory drug lisofylline , 1998, Journal of Neuroimmunology.

[17]  W. Suarez-Pinzon,et al.  Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. , 1998, Biochemical pharmacology.

[18]  C. Wollheim,et al.  Effects of depletion of mitochondrial DNA in metabolism secretion coupling in INS-1 cells. , 1998, Diabetes.

[19]  D. Peterson,et al.  Mechanism of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction , 1997, Journal of neurochemistry.

[20]  T. Pozzan,et al.  Mitochondrial activation directly triggers the exocytosis of insulin in permeabilized pancreatic β‐cells , 1997, The EMBO journal.

[21]  R. van Furth,et al.  Effect of lisofylline and pentoxifylline on the bacterial‐stimulated production of TNF‐α, IL‐1β and IL‐10 by human leucocytes , 1997, Immunology.

[22]  T. Schermerhorn,et al.  Two signaling pathways, from the upper glycolytic flux and from the mitochondria, converge to potentiate insulin release. , 1997, Endocrinology.

[23]  D. Bleich,et al.  Lisofylline, an inhibitor of unsaturated phosphatidic acid generation, ameliorates interleukin-1 beta-induced dysfunction in cultured rat islets. , 1996, Endocrinology.

[24]  Guido Kroemer,et al.  Mitochondria and programmed cell death: back to the future , 1996, FEBS letters.

[25]  B. Wolf,et al.  Wortmannin Inhibits Insulin Secretion in Pancreatic Islets and β-TC3 Cells Independent of Its Inhibition of Phosphatidylinositol 3-Kinase , 1996, Diabetes.

[26]  W. Suarez-Pinzon,et al.  Cytokine Gene Expression in Pancreatic Islet-Infiltrating Leukocytes of BB Rats: Expression of Th1 Cytokines Correlates With β-Cell Destructive Insulitis and IDDM , 1996, Diabetes.

[27]  W. Suarez-Pinzon,et al.  DNA fragmentation is an early event in cytokine-induced islet beta-cell destruction , 1994, Diabetologia.

[28]  G. Rice,et al.  Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Phillippy Bq.  Reliable luminescent detection of subpicomole amounts of ATP using a scintillation counter. , 1994 .

[30]  M. Mcdaniel,et al.  IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. , 1993, Biochemistry.

[31]  M. Berridge,et al.  Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. , 1993, Archives of biochemistry and biophysics.

[32]  M. Mcdaniel,et al.  Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Prentki,et al.  Dehydroepiandrosterone Sulfate and-Cell Function Enhanced Glucose-Induced Insulin Secretion and Altered Gene Expression in Rodent Pancreatic-Cells , 2000 .

[34]  E. Nudelman,et al.  Lisofylline causes rapid and prolonged suppression of serum levels of free fatty acids. , 1998, The Journal of pharmacology and experimental therapeutics.

[35]  B. Phillippy.  Reliable luminescent detection of subpicomole amounts of ATP using a scintillation counter. , 1994, BioTechniques.

[36]  C B Wollheim,et al.  Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. , 1992, Endocrinology.